Frennby B, Sterner G, Almén T, Chai C M, Jönsson B A, Månsson S
Department of Diagnostic Radiology, University of Lund, Malmö University Hospital, Sweden.
Scand J Clin Lab Invest. 1997 May;57(3):241-52. doi: 10.3109/00365519709060033.
In order to simplify and/or improve determination of glomerular filtration rate (GFR) the clearances of iohexol, 51Cr-EDTA and endogenous creatinine were simultaneously determined with different techniques in 21 anesthetized landrace pigs. Their GFR had been reduced to about 1/3 or less of normal GFR. After an intravenous bolus of the GFR markers, their plasma concentration curves were followed for 6 hours with 16 plasma samples. A bladder catheter collected urine during six 60-min periods. The plasma clearance was calculated by dividing "dose of marker" with "area under the plasma concentration curve" (AUC) from the time of injection to infinity using a one- (Clprovisional) and a three-compartment (ClAUC-3comp) model. The renal clearance of iohexol and 51Cr-EDTA was calculated by dividing the amount of marker excreted in the urine in a period by AUC in the same period. The AUC was for iohexol and 51Cr-EDTA determined by integrating the total area in the period (Clren adv)-our reference method representing the "true" GFR and for creatinine determined by using the arithmetic mean of the plasma concentration of the marker at the start and at the end of the urine collection period (Clren simple). Renal clearance of creatinine was significantly lower than renal clearance of iohexol (p = 0.0019) and 51Cr-EDTA (p = 0.0001). There were no significant differences between the renal clearances (Clren adv) of iohexol and 51Cr-EDTA or between their plasma clearances (ClAUC-3comp). For iohexol the median overestimation of the "true" GFR with Clprovisional was higher when "early" plasma samples (30-120 min) were used (4.5 ml min-1 10 kg-1) than when late samples (180-360 min) were used (1.9 ml min-1 10 kg-1). Subtraction of the median extrarenal clearance (known from a study of nephrectomized pigs) from the plasma clearances (ClAUC-3comp) of iohexol and 51Cr-EDTA in pigs with reduced renal function decreased the median overestimation of the "true" GFR from 1.9 to 1.0 ml min-1 10 kg-1 with iohexol and from 1.7 to 0.9 ml min-1 10 kg-1 with 51Cr-EDTA. The plasma clearance technique may be improved in pigs with reduced GFR by (i) including a "late" plasma sample in three- and one-compartment models, which tends to increase the AUC; (ii) introducing a correction formula by normalizing the GFR values of the one-compartment model to those of the three-compartment model, thereby compensating for the rapid early changes in plasma concentration of marker after the bolus injection of the marker; or (iii) subtracting a median (or mean) extrarenal clearance of the marker in pigs from the plasma clearance [according to (i) or (ii)]. The plasma clearance one-compartment technique may be improved in pigs with various levels of GFR values by normalizing the plasma clearance values to the renal clearance values, thereby compensating for both the early changes in plasma concentration of marker and the extrarenal clearance of marker.
为了简化和/或改进肾小球滤过率(GFR)的测定,在21头麻醉的长白猪中,采用不同技术同时测定了碘海醇、51铬-乙二胺四乙酸(51Cr-EDTA)和内生肌酐的清除率。它们的GFR已降至正常GFR的约1/3或更低。静脉推注GFR标志物后,采集16份血浆样本,追踪其血浆浓度曲线6小时。通过膀胱导管在六个60分钟时间段内收集尿液。血浆清除率通过将“标志物剂量”除以从注射时间到无穷大的“血浆浓度曲线下面积”(AUC)来计算,使用单室(Clprovisional)和三室(ClAUC-3comp)模型。碘海醇和51Cr-EDTA的肾清除率通过将某一时间段内尿中排泄的标志物量除以同一时间段的AUC来计算。碘海醇和51Cr-EDTA的AUC通过对该时间段内的总面积进行积分来确定(Clren adv)——我们的参考方法代表“真实”GFR,而肌酐的AUC通过使用尿液收集期开始和结束时标志物血浆浓度的算术平均值来确定(Clren simple)。肌酐的肾清除率显著低于碘海醇的肾清除率(p = 0.0019)和51Cr-EDTA的肾清除率(p = 0.0001)。碘海醇和51Cr-EDTA的肾清除率(Clren adv)之间或它们的血浆清除率(ClAUC-3comp)之间没有显著差异。对于碘海醇,当使用“早期”血浆样本(30 - 120分钟)时,Clprovisional对“真实”GFR的中位数高估(4.5毫升·分钟-1·10千克-1)高于使用晚期样本(180 - 360分钟)时(1.9毫升·分钟-1·10千克-1)。从肾功能降低的猪的碘海醇和51Cr-EDTA的血浆清除率(ClAUC-3comp)中减去肾外清除率中位数(来自对肾切除猪的研究),碘海醇使“真实”GFR的中位数高估从1.9降至1.0毫升·分钟-1·10千克-1,51Cr-EDTA使中位数高估从1.7降至0.9毫升·分钟-1·10千克-1。对于GFR降低猪的血浆清除率技术,可通过以下方法改进:(i)在三室和单室模型中纳入“晚期”血浆样本,这往往会增加AUC;(ii)引入校正公式,将单室模型的GFR值归一化为三室模型的GFR值,从而补偿推注标志物后血浆中标志物浓度的早期快速变化;或(iii)从血浆清除率中减去猪体内标志物的肾外清除率中位数(或平均值)[根据(i)或(ii)]。通过将血浆清除率值归一化为肾清除率值,可改进不同GFR值水平猪的血浆清除率单室技术,从而补偿血浆中标志物浓度的早期变化和标志物的肾外清除率。